# OnCo record rejuv-ayac-services (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/rejuv-ayac-services/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "rejuv-ayac-services" ;
  schema:name "Services built for teenagers and young adults, and what the national evaluation found"@en ;
  schema:description "England built specialist units for 13 to 24 year olds and then evaluated them nationally, which almost no health system does. The results were mixed enough that young people were asked to interpret them, and they pointed out that three years of follow-up was too short and that the study had defined specialist care by how many admissions a person had rather than how long they spent there."@en ;
  schema:url <https://onco.cc/technologies/rejuv-ayac-services/> ;
  schema:dateModified "2026-10-02"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Teenage_Cancer_Trust> ;
  schema:citation <https://doi.org/10.1186/s40900-025-00739-7>, <https://doi.org/10.3390/healthcare13151821>, <https://www.nice.org.uk/guidance/qs55>, <https://www.nice.org.uk/guidance/csg7>, <https://www.cancerresearchuk.org/health-professional/cancer-statistics/teenagers-and-young-adults-cancers> ;
  onco:status "established" ;
  onco:tag "rejuvenation", "survivorship", "paediatric", "late-effects", "evidence:moderate" ;
  onco:related <https://onco.cc/institutions/teenage-cancer-trust/>, <https://onco.cc/ideas/idea-acc-aya-survivorship-passport/> ;
  onco:cancers <https://onco.cc/cancers/hodgkin-lymphoma/>, <https://onco.cc/cancers/all-leukemia/>, <https://onco.cc/cancers/osteosarcoma/>, <https://onco.cc/cancers/ewing-sarcoma/>, <https://onco.cc/cancers/testicular/>, <https://onco.cc/cancers/childhood-cancers/> ;
  onco:sections <https://onco.cc/fronts/rejuvenation/>, <https://onco.cc/fronts/supportive-care/> ;
  onco:technologies <https://onco.cc/technologies/rejuv-ayac-distinct-group/>, <https://onco.cc/technologies/rejuv-ayac-education-and-work/>, <https://onco.cc/technologies/rejuv-ayac-diagnostic-delay/>, <https://onco.cc/technologies/rejuv-paed-uk-long-term-follow-up/>, <https://onco.cc/technologies/rejuv-paed-transition-to-adult-care/>, <https://onco.cc/technologies/fertility-preservation/> ;
  onco:terms <https://onco.cc/terms/quality-of-life/>, <https://onco.cc/terms/late-effects/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-survivorship/>, <https://onco.cc/bottlenecks/b-care-fragmentation/>, <https://onco.cc/bottlenecks/b-patient-voice/> .